Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05938569 · ClinicalTrials.gov registry record · NA
Computer-Assisted Hair Restoration Study Using ARTAS System
A NA study of Androgenic Alopecia, sponsored by Venus Concept.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 2
- Study locations
NCT05938569: Recruiting NA study of Androgenic Alopecia, sponsored by Venus Concept.
NCT05938569 is a NA study of Androgenic Alopecia that is actively recruiting participants, run by Venus Concept. The registered enrollment target is 150 participants, above the 40-participant average among 4 other Androgenic Alopecia trials with a reported enrollment target (275% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05938569, a NA study of Androgenic Alopecia, is actively recruiting participants, sponsored by Venus Concept.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
Prospective, multi-center, up to 4 investigational centers evaluating the performance of the ARTAS System in Hair Restoration Procedures.
Conditions Studied
Interventions
- DEVICE Hair restoration
Study Locations (2)
California
- Berman Skin Institute - Los Altos
- Le's Aesthetics - San Jose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2016-11-03 |
| Est. Completion | 2026-12-15 |
| Phase | NA |
What NCT05938569 shows while recruiting
NCT05938569 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 40-participant average among 4 other Androgenic Alopecia trials with a reported enrollment target (275% higher).
The record links to 1 condition, with Androgenic Alopecia appearing as the primary indexed condition, and to 1 intervention - of which Hair restoration is the first listed.
NCT05938569 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05938569 about?
NCT05938569 is a clinical study titled "Computer-Assisted Hair Restoration Study Using ARTAS System". Prospective, multi-center, up to 4 investigational centers evaluating the performance of the ARTAS System in Hair Restoration Procedures.
What is the current status of trial NCT05938569?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2016-11-03. Estimated completion is 2026-12-15.
What conditions does trial NCT05938569 study?
This clinical trial studies the following conditions: Androgenic Alopecia.
What interventions are being tested in trial NCT05938569?
The interventions under investigation include: Hair restoration (DEVICE).
Who is sponsoring clinical trial NCT05938569?
This trial is sponsored by Venus Concept, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05938569 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Androgenic Alopecia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)
RECRUITING · NA
-
Keravive by Hydrafacial for Scalp Health and Enhanced Hair Quality
COMPLETED · NA
-
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss
COMPLETED · NA
-
Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI